Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RLAY Relay Therapeutics > Main Composition
RLAY Relay Therapeutics
18.4100.0000.00%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Single Segment--3.03M100.00%
Region Unit:USD
nameYOYOperating income%
United States--3.03M100.00%
Company Overview More
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
CEO: Mr. Sanjiv K. Patel, M.D.
Market: NASDAQ
Listing Date: 07/16/2020
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist